Press Releases
Humanetics Corporation and Pharmaceutics International, Inc. Announce Partnership in Support of BIO 300 Clinical Trials in COVID-19 Patients
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos Humanetics Corporation and Pharmaceutics International, Inc.Announce Partnership in Support of BIO 300 Clinical Trials in COVID-19 Patients PRESS RELEASE Hunt Valley, MD (August 19, 2020) Humanetics Corporation and Pharmaceutics International, Inc. (Pii) will work…
Read MoreAspargo Laboratories, Inc. Announces Successful Completion of Pre-IND Meeting with FDA on Sildenafil Oral Spray for the Treatment of Erectile Dysfunction – May 2020
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos Alignment with FDA to pursue 505(b)(2) regulatory pathwayOn-track for IND filing in Q3 2020 ENGLEWOOD CLIFFS, N.J., May 04, 2020 (GLOBE NEWSWIRE) — Aspargo Laboratories, Inc. (Aspargo), a privately held, clinical stage pharmaceutical company,…
Read MorePharmaceutics International, Inc. Announces $100,000 Grant for a First-in-Human Project – July 2020
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos Pharmaceutics International, Inc. Announces $100,000 Grant for a First-in-Human Project PRESS RELEASE Hunt Valley, MD (July 14, 2020) Pharmaceutics International, Inc. (Pii) is offering a $100,000 grant for a promising early-stage drug therapy. An…
Read MorePharmaceutics International, Inc. (Pii) – A Key Part of the FDA’s 503B Solution – July 2020
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos Pharmaceutics International, Inc. (Pii) – A Key Part of the FDA’s 503B Solution PRESS RELEASE Hunt Valley, MD (July 2, 2020) Pharmaceutics International, Inc. (Pii) has been added to the FDA’s list of organizations…
Read MorePharmaceutics International Selected As A Winner Of Multiple 2020 CMO Leadership Awards
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos Pharmaceutics International Selected As A Winner Of Multiple 2020 CMO Leadership Awards Hunt Valley, MD – March 2, 2020 /PRNewswire/ – Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) today announced…
Read MorePharmaceutics International, Inc (Pii) and Its Partners Received FDA Market Approval for Seven Products and Commercially Launched 6 Products in 2017 – February 2018
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos Pharmaceutics International, Inc (Pii) and Its Partners Received FDA Market Approval for Seven Products and Commercially Launched 6 Products in 2017 HUNT VALLEY, MARYLAND (February 8, 2018) – Pharmaceutics International, Inc. (Pii), a Contract…
Read MorePharmaceutics International, Inc (Pii) Fills Key Leadership Position with New Vice President of Business Development – November 2018
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos Pharmaceutics International, Inc (Pii) Fills Key Leadership Position with New Vice President of Business Development HUNT VALLEY, MARYLAND, November 7, 2018/PRNewswire/ – Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) headquartered…
Read MorePharmaceutics International, Inc (Pii) to Manufacture FDA-approved Bretylium Tosylate Injection Drug Product – January 2019
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos Pharmaceutics International, Inc (Pii) to Manufacture FDA-approved Bretylium Tosylate Injection Drug Product – January 2019 HUNT VALLEY, MARYLAND (January 9, 2019) – Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) headquartered…
Read MoreNemus Bioscience Announces Signed Agreement with Pharmaceuticals International, Inc (Pii) to Develop Dosage Formulation for Human Dosing with Nb1111 for Glaucoma – February 2019
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos Nemus Bioscience Announces Signed Agreement with Pharmaceuticals International, Inc (Pii) to Develop Dosage Formulation for Human Dosing with Nb1111 for Glaucoma – February 2019 Long Beach, February 14, 2019 — Nemus Bioscience, Inc. (OTCQB:…
Read MorePharmaceutics International, Inc (Pii) Selected as Winner of 2019 CMO Leadership Award – March 2019
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos Pharmaceutics International, Inc (Pii) Selected as Winner of 2019 CMO Leadership Award – March 2019 Hunt Valley, MD – March 4, 2019 – Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO)…
Read More